Katherine Ma O’Reilly

2.0k total citations
33 papers, 1.1k citations indexed

About

Katherine Ma O’Reilly is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Katherine Ma O’Reilly has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Infectious Diseases. Recurrent topics in Katherine Ma O’Reilly's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers), Occupational and environmental lung diseases (5 papers) and COVID-19 Clinical Research Studies (4 papers). Katherine Ma O’Reilly is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers), Occupational and environmental lung diseases (5 papers) and COVID-19 Clinical Research Studies (4 papers). Katherine Ma O’Reilly collaborates with scholars based in Ireland, United Kingdom and United States. Katherine Ma O’Reilly's co-authors include Patricia J. Sime, Richard P. Phipps, Carolyn J. Baglole, Stephen J. Pollock, Vicky R Copley, Jill L Colquitt, Emma Loveman, Andrew Clegg, David A. Scott and Athol U. Wells and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and PLoS Biology.

In The Last Decade

Katherine Ma O’Reilly

31 papers receiving 1.1k citations

Peers

Countries citing papers authored by Katherine Ma O’Reilly

Since Specialization

Citations

This map shows the geographic impact of Katherine Ma O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Ma O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Ma O’Reilly more than expected).

Fields of papers citing papers by Katherine Ma O’Reilly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Ma O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Ma O’Reilly. The network helps show where Katherine Ma O’Reilly may publish in the future.

Co-authorship network of co-authors of Katherine Ma O’Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Ma O’Reilly. A scholar is included among the top collaborators of Katherine Ma O’Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Ma O’Reilly. Katherine Ma O’Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A qualitative exploration of people living with idiopathic pulmonary fibrosis experience of a virtual pulmonary rehabilitation programme 2022 ·BMC Pulmonary Medicine ·(unknown), (unknown), (unknown), Katherine Ma O’Reilly	6
2	Estimating the national carbon footprint of inhalers in healthcare 2022 ·Irish Journal of Medical Science (1971 -) ·(unknown), (unknown), (unknown), Katherine Ma O’Reilly, (unknown), John M. Allman, (unknown), (unknown), (unknown)	4
3	Mixed methods protocol to examine the acceptability and clinical characteristics of a remote monitoring programme for delivery of COVID-19 care, among healthcare staff and patients 2021 ·BMJ Open ·Robert Fox, Sophie Mulcahy Symmons, Aoife De Brún, (unknown), Eavan G. Muldoon, Tara McGinty, Katherine Ma O’Reilly, (unknown), Éilish McAuliffe	3
4	Routine Hematological Parameters May Be Predictors of COVID-19 Severity 2021 ·Frontiers in Medicine ·Paulina B. Szklanna, (unknown), (unknown), Sarah Cullivan, (unknown), Luisa Weiß, John S. Curran, (unknown), Katherine Ma O’Reilly, Aoife G. Cotter, Brian Marsh, Seán Gaine, Nick Power, (unknown), Brian McCullagh, Fionnuala Ní Áinle, Barry Kevane, Patricia B. Maguire	17
5	COVID-19 induces a hyperactive phenotype in circulating platelets 2021 ·PLoS Biology ·(unknown), Sarah Cullivan, Paulina B. Szklanna, Luisa Weiß, (unknown), (unknown), Albert Smolenski, Claire Murphy, (unknown), John S. Curran, Katherine Ma O’Reilly, Aoife G. Cotter, Brian Marsh, Seán Gaine, Patrick Mallon, Brian McCullagh, Niamh Moran, Fionnuala Ní Áinle, Barry Kevane, Patricia B. Maguire, (unknown)	96
6	Time taken from primary care referral to a specialist centre diagnosis of idiopathic pulmonary fibrosis: an opportunity to improve patient outcomes? 2020 ·ERJ Open Research ·Christopher J. Brereton, T Wallis, Michelle Casey, (unknown), (unknown), D. Richard Laws, (unknown), (unknown), (unknown), (unknown), A Grove, (unknown), Luca Richeldi, Katherine Ma O’Reilly, Sophie Fletcher, Mark G. Jones	18
7	Innovative Solutions to Facilitate Accessibility for Airport Travelers with Disabilities 2020 ·Transportation Research Board eBooks ·(unknown), Eric Lipp, Katherine Ma O’Reilly, (unknown), (unknown), (unknown), (unknown), Shu Cole, (unknown)	2
8	An Observational Study of Self-Monitoring of Spirometry and Symptoms via a Mobile Electronic Health Journal in Usual Care of Patients with Idiopathic Pulmonary Fibrosis 2020 ·(unknown), (unknown), Anne‐Marie Russell, C. Edwards, Katherine Ma O’Reilly	2
9	Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis 2016 ·JCI Insight ·Mark G. Jones, Aurélie Fabre, Philipp Schneider, Francesco Cinetto, Giacomo Sgalla, Mark Mavrogordato, Sanjay Jogai, Aiman Alzetani, Ben G. Marshall, Katherine Ma O’Reilly, Jane A. Warner, Peter M. Lackie, Donna E. Davies, David M. Hansell, Andrew G. Nicholson, Ian Sinclair, Kevin M. Brown, Luca Richeldi	70
10	Unexpected paracetamol (acetaminophen) hepatotoxicity at standard dosage in two older patients: time to rethink 1 g four times daily?: Table 1. 2016 ·Age and Ageing ·(unknown), (unknown), Katherine Ma O’Reilly	11
11	The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation 2015 ·Health Technology Assessment ·Emma Loveman, Vicky R Copley, Jill L Colquitt, David A. Scott, Andrew Clegg, Jeremy Jones, Katherine Ma O’Reilly, Sally Singh, Claudia Bausewein, Athol U. Wells	31
12	Comparing new treatments for idiopathic pulmonary fibrosis – a network meta-analysis 2015 ·BMC Pulmonary Medicine ·Emma Loveman, Vicky R Copley, David A. Scott, Jill L Colquitt, Andrew Clegg, Katherine Ma O’Reilly	46
13	Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia 2014 ·American Journal of Respiratory and Critical Care Medicine ·Tamera J. Corte, Gregory J. Keir, Konstantinos Dimopoulos, Luke Howard, Paul A. Corris, Lisa Parfitt, Claire Foley, (unknown), Daphne Babalis, Philip Marino, Toby M. Maher, Elisabetta Renzoni, Lisa Spencer, Charlie Elliot, Surinder S. Birring, Katherine Ma O’Reilly, Michael Α. Gatzoulis, Athol U. Wells, Stephen J. Wort	153
14	The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation 2014 ·BMC Pharmacology and Toxicology ·Emma Loveman, Vicky R Copley, Jill L Colquitt, David A. Scott, Andrew Clegg, Jeremy Jones, Katherine Ma O’Reilly, Sally Singh, Claudia Bausewein, Athol U. Wells	40
15	Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia: A randomized, double-blind, placebo-controlled study 2013 ·European Respiratory Journal ·Gregory J. Keir, Tamera J. Corte, Lisa Parfitt, Toby M. Maher, (unknown), Elisabetta Renzoni, Konstantinos Dimopoulos, Michael Α. Gatzoulis, (unknown), Luke Howard, Paul A. Corris, Katherine Ma O’Reilly, (unknown), Surinder S. Birring, Athol U. Wells, SJ Wort	3
16	Spiruchostatin A Inhibits Proliferation and Differentiation of Fibroblasts from Patients with Pulmonary Fibrosis 2012 ·American Journal of Respiratory Cell and Molecular Biology ·Elizabeth R. Davies, Hans Michael Haitchi, Thomas H. Thatcher, Patricia J. Sime, R.M. Kottmann, A. Ganesan, Graham Packham, Katherine Ma O’Reilly, Donna E. Davies	50
17	Persistent Culture-Positive Legionella Infection in an Immunocompromised Host 2005 ·Clinical Infectious Diseases ·Katherine Ma O’Reilly, (unknown), (unknown), Robert F. Betts, (unknown)	15
18	Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E₂synthase in human lung fibroblasts: implications for lung inflammation and cancer 2004 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·(unknown), Stephen J. Pollock, (unknown), Katherine Ma O’Reilly, Carolyn J. Baglole, Richard P. Phipps, Patricia J. Sime	180
19	Fibrosis of the Lung and Other Tissues: New Concepts in Pathogenesis and Treatment 2001 ·Clinical Immunology ·Patricia J. Sime, Katherine Ma O’Reilly	289
20	Polymyositis: a cause of acute renal failure 1996 ·Nephrology Dialysis Transplantation ·Andrew Lewington, Richard D’Souza, Sue Carr, Katherine Ma O’Reilly, Graham Warwick	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact